This is Justin C. Hallberg's Typepad Profile.
Join Typepad and start following Justin C. Hallberg's activity
Join Now!
Already a member? Sign In
Justin C. Hallberg
Recent Activity
As social media evolves, it keeps finding new ways for people to connect, stay connected, share information, and define ourselves. New social media developments often expose what a person keeps private, yet people seem willing to trade some privacy for the ability to connect with others. Think about how much... Continue reading
Posted Mar 9, 2011 at Pharmaspective
This is Part 1 of our examination into the iPad's potential impact on the life sciences industry, particularly the industry’s interactions with physicians, selling model, compliance efforts, and relationship with patients. This week, nearly one year after the first iPad was released, Apple CEO Steve Jobs took a break from... Continue reading
Posted Mar 4, 2011 at Pharmaspective
On February 24th, Pharmaspective highlighted the different opinions among federal courts as to whether pharmaceutical sales representatives should be entitled to overtime pay. The issue is back in the news, as the U.S. Supreme Court refused to examine the issue despite the circuit split. The Second Circuit reached the conclusion... Continue reading
Posted Mar 2, 2011 at Pharmaspective
The recent economic downturn impacted everyone from Wall Street to Main Street, including your local, state, and federal government. It’s in the news on a daily basis – every level of government has budget concerns. Elected officials are trying to close billion dollar budget gaps without raising taxes by making... Continue reading
Posted Feb 25, 2011 at Pharmaspective
On February 14, 2011, the United States Court of Appeals for the Ninth Circuit ruled that pharmaceutical sales representatives are not entitled to overtime pay under the Fair Labor Standards Act of 1938 (“FLSA”). Christopher v. SmithKlineBeecham Corp., No. 10-15257 D.C. No. 2:08-cv-01498-FJM (9th Cir. Feb. 14, 2011). The plaintiffs,... Continue reading
Posted Feb 24, 2011 at Pharmaspective
Undoubtedly, the life sciences industry is one of the most heavily regulated industries in the nation. When viewing the detailed regulatory landscape impacting the industry, it is interesting to note the power that our system of government bestows on each state, no matter the size or prominence. One outlier state... Continue reading
Posted Feb 18, 2011 at Pharmaspective
Earlier this week, the FDA held a public workshop titled, “Determination of System Attributes for the Tracking and Tracing of Prescription Drugs.” Consistent with the Food and Drug Administration Amendments Act of 2007, the FDA seeks to protect consumers from dangerous counterfeit and adulterated drug products by implementing track and... Continue reading
Posted Feb 17, 2011 at Pharmaspective
Facing imminent patent cliffs, fierce competition, and a challenging market, several large life sciences companies have been acquiring smaller niche companies or partnering with other large companies at a rapid pace. Such strategic acquisitions or partnerships can immediately strengthen a product pipeline, bolster market share, or create a presence in... Continue reading
Posted Feb 9, 2011 at Pharmaspective
Jeanne Whalen recently reported in The Wall Street Journal that GlaxoSmithKline PLC took a $3.49 billion charge in the fourth quarter of 2010 to pay for expenses associated with, in part, federal government investigations into its marketing practices for various products. Reportedly, it also included litigation costs related to Avandia.... Continue reading
Posted Feb 7, 2011 at Pharmaspective
A quick scan of recent industry-related headlines suggests that life sciences companies have increased their sales forces in emerging markets, such as China, Brazil and Russia; opened up subsidiaries in emerging markets, like India; and investigated forming partnerships with emerging market-based life sciences companies. Obviously, the life sciences industry is... Continue reading
Posted Feb 2, 2011 at Pharmaspective
Do you remember the first time you used the Internet? I do – and I’m not sure how I survived before that glorious day. Needless to say, the Internet is now an integral part of our personal and professional lives. Social media is a large part of why that has... Continue reading
Posted Feb 1, 2011 at Pharmaspective
Welcome to Pharmaspective, the convergence of compliance, technology, and life sciences. Pharmaspective is a blog brought to you by Porzio Pharmaceutical Services, LLC, a longtime compliance and regulatory consultant for several life sciences companies of varying size. As Pharmaspective’s primary blogger, my objective is to provide you – the life... Continue reading
Posted Jan 31, 2011 at Pharmaspective
Justin C. Hallberg is now following The Typepad Team
Jan 28, 2011